Charles River Laboratories International (CRL) Income from Non-Controlling Interests (2009 - 2026)
Charles River Laboratories International (CRL) recorded Income from Non-Controlling Interests of $722,000 in Q2 2026, up 96.7% from $367,000 a year earlier.
Powered by 
Analysis
Charles River Laboratories International (CRL) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends
On a TTM basis, Charles River Laboratories International's Income from Non-Controlling Interests came in at $2.16 million as of Jun 27, 2026, unchanged year-over-year; for FY2025, it was $2.18 million, down 29.6% from FY2024.
- Annual Income from Non-Controlling Interests has declined for four straight years, though with a five-year compound annual growth rate of 16.8% (FY2020 to FY2025).
- Across earlier years, Income from Non-Controlling Interests came in at $3.09 million in FY2024 (-46.3%), $5.75 million in FY2023 (-10.0%), $6.38 million in FY2022 (-18.8%) and $7.86 million in FY2021 (+683.9%).
- Quarterly Income from Non-Controlling Interests has ranged from $41,000 in Q1 2026 to $2.42 million in Q2 2023 over the past five years.
- On a year-over-year basis, Income from Non-Controlling Interests rose in four of the last eight quarters, with an average decline of 1.0%.
- Peak year-over-year performance for Income from Non-Controlling Interests in the last five years was growth of 125.1% in Q4 2021, against a decline of 92.6% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $41,000 (Q1 2026), $265,000 (Q4 2025) and $1.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 43.58 Bn | 35.28 Bn | 1.44 Bn | 2.00 Mn |
| 2 | Medpace Holdings | 17.39 Bn | 15.45 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 14.59 Bn | 13.78 Bn | 363.37 Mn | 722,000.00 |
| 4 | Icon | 13.27 Bn | 10.38 Bn | 479.29 Mn | - |
| 5 | Fortrea Holdings | 2.03 Bn | 1.41 Bn | 139.20 Mn | - |
| 6 | Ginkgo Bioworks Holdings | 716.57 Mn | -45.52 Mn | 18.44 Mn | - |
| 7 | Evotec SE | 506.10 Mn | -1.10 Bn | - | - |
| 8 | Champions Oncology | 66.85 Mn | 41.93 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 63.92 Mn | 27.58 Mn | 1.61 Mn | - |
| 10 | Natural Alternatives International | 6.75 Mn | -21.33 Mn | 1.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 722,000.00 |
| Mar 28, 2026 | 41,000.00 |
| Dec 27, 2025 | 265,000.00 |
| Sep 27, 2025 | 1.13 Mn |
| Jun 28, 2025 | 367,000.00 |
| Mar 29, 2025 | 409,000.00 |
| Dec 28, 2024 | 748,000.00 |
| Sep 28, 2024 | 638,000.00 |
| Jun 29, 2024 | 180,000.00 |
| Mar 30, 2024 | 1.52 Mn |
| Dec 30, 2023 | 1.87 Mn |
| Sep 30, 2023 | 632,000.00 |
| Jul 1, 2023 | 2.42 Mn |
| Apr 1, 2023 | 823,000.00 |
| Dec 31, 2022 | 1.70 Mn |
| Sep 24, 2022 | 1.14 Mn |
| Jun 25, 2022 | 1.34 Mn |
| Mar 26, 2022 | 2.20 Mn |
| Dec 25, 2021 | 2.25 Mn |
| Sep 25, 2021 | 1.73 Mn |
API Access
Charles River Laboratories International Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CRL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "CRL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CRL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();